QUESTIONÁRIO DE ATIVIDADES FUNCIONAIS (PFEFFER)
1) Ele (Ela) manuseia seu próprio dinheiro?
0= Normal 0= Nunca o fez, mas poderia fazê-lo agora 1= Faz, com dificuldade 1= Nunca o fez e agora teria dificuldade 2= Necessita de ajuda
3= Não é capaz
2) Ele (Ela) é capaz de comprar roupas, comida, coisas para casa sozinho(a)?
0= Normal 0= Nunca o fez, mas poderia fazê-lo agora 1= Faz, com dificuldade 1= Nunca o fez e agora teria dificuldade 2= Necessita de ajuda
3= Não é capaz
3) Ele (Ela) é capaz de esquentar a água para o café e apagar o fogo?
0= Normal 0= Nunca o fez, mas poderia fazê-lo agora 1= Faz, com dificuldade 1= Nunca o fez e agora teria dificuldade 2= Necessita de ajuda
3= Não é capaz
4) Ele (Ela) é capaz de preparar uma comida?
0= Normal 0= Nunca o fez, mas poderia fazê-lo agora 1= Faz, com dificuldade 1= Nunca o fez e agora teria dificuldade 2= Necessita de ajuda
3= Não é capaz
5) Ele (Ela) é capaz de manter-se em dia com as atualidades, com os acontecimentos da comunidade ou da vizinhança?
0= Normal 0= Nunca o fez, mas poderia fazê-lo agora 1= Faz, com dificuldade 1= Nunca o fez e agora teria dificuldade 2= Necessita de ajuda
3= Não é capaz
6) Ele (Ela) é capaz de prestar atenção, entender e discutir um programa de rádio ou televisão, um jornal ou uma revista?
0= Normal 0= Nunca o fez, mas poderia fazê-lo agora 1= Faz, com dificuldade 1= Nunca o fez e agora teria dificuldade 2= Necessita de ajuda
3= Não é capaz
7) Ele (Ela) é capaz de lembrar-se de compromissos, acontecimentos familiares, feriados? 0= Normal 0= Nunca o fez, mas poderia fazê-lo agora 1= Faz, com dificuldade 1= Nunca o fez e agora teria dificuldade 2= Necessita de ajuda
3= Não é capaz
0= Normal 0= Nunca o fez, mas poderia fazê-lo agora 1= Faz, com dificuldade 1= Nunca o fez e agora teria dificuldade 2= Necessita de ajuda
3= Não é capaz
9) Ele (Ela) é capaz de passear pela vizinhança e encontrar o caminho de volta para casa? 0= Normal 0= Nunca o fez, mas poderia fazê-lo agora 1= Faz, com dificuldade 1= Nunca o fez e agora teria dificuldade 2= Necessita de ajuda
3= Não é capaz
10) Ele (Ela) pode ser deixado(a) em casa sozinho(a) de forma segura?
0= Normal 0= Nunca ficou, mas poderia ficar agora 1= Sim, mas com precauções 1= Nunca ficou e agora teria dificuldade 2= Sim, por períodos curtos
3= Não poderia
Clinical and neuropathological criteria for frontotemporal dementia. The Lund and Manchester Groups. J Neurol Neurosurg Psychiatry. 1994 Apr;57(4):416-8. Aggarwal A, Aggarwal N, Nagral A, Jankharia G, Bhatt M. A novel Global
Assessment Scale for Wilson's Disease (GAS for WD). Mov Disord. 2009;24(4):509-518.
Al JM, Majumdar R, Al RS, Awada A, Al ZA, Al TI et al. A clinical and genetic study of 56 Saudi Wilson disease patients: identification of Saudi-specific mutations. Eur J Neurol. 2004;11(2):121-124.
Ala A, Walker AP, Ashkan K, Dooley JS, Schilsky ML. Wilson's disease. Lancet. 2007;369(9559):397-408.
Arango-Lasprilla JC, Rogers H, Lengenfelder J, Deluca J, Moreno S, Lopera F. Cortical and subcortical diseases: do true neuropsychological differences exist?
Arch Clin Neuropsychol. 2006;21(1):29-40.
Asadi Pooya AA, Eslami NS, Haghighat M. Wilson disease in southern Iran. Turk J
Gastroenterol. 2005;16(2):71-74.
Auclair L, Sieroff E, Kocer S. A case of spatial neglect dysgraphia in Wilson's Disease. Arch Clin Neuropsychol. 2008;23(1):47-62.
Bandettin, P. (2002). A short history of statistical parametric mapping in functional neuroimaging.
Barbosa ER. Degeneração hepatolenticular: Aspectos terapêuticos em 76 casos [tese]. São Paulo: Faculdade de Medicina, Universidade de São Paulo, 1990. Barbosa ER. O zinco no tratamento da Doença de Wilson: Estudo de 20 casos [tese].
Barbosa ER, Burdmann EDE, Cançado ER, Haddad MS, Scaff M, Canelas HM. O zinco no tratamento da degeneração hepatolenticular: relato de 3 casos. Arq Neuropsiquiatr. 1992;50:99-103.
Barbosa ER, Caramelli P, Bacheschi LA, Haddad MS, Magalhães AC, Menezes JR. et al. (1993). Wilson's disease: magnetic resonance imaging (MRI) with clinical correlations in 16 cases. Rev Paul Med. 1993;111(3):407-411.
Barbosa ER, Machado AA, Cançado EL, Deguti MM, Scaff M. Wilson's disease: a case report and a historical review. Arq Neuropsiquiatr. 2009;67(2B):539-543. Barthel H, Hermann W, Kluge R, Hesse S, Collingridge DR, Wagner A, et al.
Concordant pre- and postsynaptic deficits of dopaminergic neurotransmission in neurologic Wilson disease. AJNR Am J Neuroradiol. 2003;24(2):234-238. Barthel H, Sorger D, Kuhn HJ, Wagner A, Kluge R, Hermann W. Differential
alteration of the nigrostriatal dopaminergic system in Wilson's disease investigated with [123I]ss-CIT and high-resolution SPET. Eur J Nucl Med. 2001;28(11):1656-1663.
Beato RG, Nitrini R, Formigoni AP, Caramelli P. Brazilian version of the frontal assessment battery (FAB): preliminary data on administration to healthy elderly. Dementia & Neuropsychologia. 2007;1:59-65.
Bertolucci PH, Okamoto IH, Brucki SM, Siviero MO, Toniolo NJ, Ramos LR. Applicability of the CERAD neuropsychological battery to Brazilian elderly.
Arq Neuropsiquiatr. 2001;59(3-A), 532-536.
Bowcock AM, Farrer LA, Cavalli-Sforza LL, Hebert JM, Kidd KK, Frydman M, et al. Mapping the Wilson disease locus to a cluster of linked polymorphic markers on chromosome 13. Am J Hum Genet. 1987;41(1):27-35.
Brewer GJ, Fink JK, Hedera P. Diagnosis and treatment of Wilson's disease. Semin
Neurol. 1999;19(3):261-270.
Brucki SM, Nitrini R, Caramelli P, Bertolucci PH, Okamoto IH. Suggestions for utilization of the mini-mental state examination in Brazil. Arq Neuropsiquiatr. 2003;61(3B):777-781.
Bull PC, Thomas GR, Rommens JM, Forbes JR, Cox DW. The Wilson disease gene is a putative copper transporting P-type ATPase similar to the Menkes gene.
Nat Genet. 1993;5(4):327-337.
Canning SJ, Leach L, Stuss D, Ngo L, Black SE. Diagnostic utility of abbreviated fluency measures in Alzheimer disease and vascular dementia. Neurology 2004;62(4):556-562.
Carthery-Goulart MT, Anghinah R, Areza-Fegyveres R, Bahia VS, Brucki SM, Damin A. et al. Performance of a Brazilian population on the test of functional health literacy in adults. Rev Saude Publica. 2009;43(4):631-638.
Castiglioni S, Pelati O, Zuffi M, Somalvico F, Marino L, Tentorio T. et al. The frontal assessment battery does not differentiate frontotemporal dementia from Alzheimer's disease. Dement Geriatr Cogn Disord. 2006;22(2):125-131.
Chaves ML, Camozzato AL, Köhler C, Kaye J. Predictors of the progression of dementia severity in Brazilian patients with Alzheimer's disease and vascular dementia. Int J Alzheimers Dis. 2010.
Cordato DJ, Fulham MJ, Yiannikas C. Pretreatment and posttreatment positron emission tomographic scan imaging in a 20-year-old patient with Wilson's disease. Mov Disord. 1998;13(1):162-166.
Costa MD, Spitz M, Bacheschi LA, Leite CC, Lucato LT, Barbosa ER. Wilson's disease: two treatment modalities. Correlations to pretreatment and posttreatment brain MRI. Neuroradiology. 2009;51(10):627-633.
Cummings JL. Subcortical dementia. Neuropsychology, neuropsychiatry, and pathophysiology. Br J Psychiatry. 1986;149:682-697.
Cummings JL, Benson DF. Dementia: a clinical approach. 2a. ed. Boston: Butterworth-Heineman, 1992.
Cunha PJ, Nicastri S, de Andrade AG, Bolla KI. The frontal assessment battery (FAB) reveals neurocognitive dysfunction in substance-dependent individuals in distinct executive domains: Abstract reasoning, motor programming, and cognitive flexibility. Addict Behav. 2010;35(10):875-881.
Daffner KR, Searl MM. The dysexecutive syndromes. In: Handbook of clinical
neurology, neuropsychology and behavioral neurology. 3a. ed. Elsevier, 2008.
Deguti MM, Genschel J, Cancado EL, Barbosa ER, Bochow B, Mucenic M, Porta G, Lochs H, Carrilho FJ, Schmidt HH. Wilson disease: novel mutations in the ATP7B gene and clinical correlation in Brazilian patients. Hum Mutat. 2004;23(4):398.
Dening TR, Berrios GE. Wilson's disease. Psychiatric symptoms in 195 cases. Arch
Gen Psychiatry. 1989a;46(12):1126-1134.
Dening TR, Berrios GE. Wilson's disease: a prospective study of psychopathology in 31 cases. Br J Psychiatry. 1989b;155:206-213.
Dening TR, Berrios GE. Wilson's disease: a longitudinal study of psychiatric symptoms. Biol Psychiatry. 1990;28(3):255-265.
Dening TR, Berrios GE, Walshe JM. Wilson's disease and epilepsy. Brain. 1988;111(Pt 5):1139-1155.
Dubois B, Slachevsky A, Litvan I, Pillon B. The FAB: a Frontal Assessment Battery at bedside. Neurology. 2000;55(11):1621-1626.
El-Youssef M. Wilson disease. Mayo Clin Proc. 2003;78(9):1126-1136.
Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12(3):189-198.
Friston KJ, Frith CD, Liddle PF, Frackowiak RS. Comparing functional (PET) images: the assessment of significant change. J Cereb Blood Flow Metab. 1991;11(4):690-699.
Frota NAF, Barbosa ER, Caramelli P. Cognitive impairment in Wilson's disease.
Dementia & Neuropsychologia. 2009;3:16-21.
Giagheddu M, Tamburini G, Piga M, Tacconi P, Giagheddu A, Serra A, et al. (2001). Comparison of MRI, EEG, EPs and ECD-SPECT in Wilson's disease. Acta
Neurol Scand. 2001;103(2):71-81.
Goldberg D, Bridges K, Duncan-Jones P, Grayson D. Detecting anxiety and depression in general medical settings. BMJ. 1988;297(6653):897-899.
Goldstein NP, Ewert JC, Randall RV, Gross JB. Psychiatric aspects of Wilson's disease (hepatolenticular degeneration): results of psychometric tests during long-term therapy. Am J Psychiatry. 1968;124(11):1555-1561.
Grant DA, Berg E. The Wisconsin Card Sort Test Random Layout: Directions for
Haddad MS, Field D, Hammond SM. Measuring memory span. Int J Psychol. 1999;34:359-363.
Hawkins RA, Mazziotta JC, Phelps ME. Wilson's disease studied with FDG and positron emission tomography. Neurology. 1987;37(11):1707-1711.
Hedera P, Brewer GJ, Fink JK. White matter changes in Wilson disease. Arch
Neurol. 2002;59(5):866-867.
Hesse S, Barthel H, Hermann W, Murai T, Kluge R, Wagner A, et al. Regional serotonin transporter availability and depression are correlated in Wilson's disease. J Neural Transm. 2003;110(8):923-933.
Hester RL, Kinsella GJ, Ong B. Effect of age on forward and backward span tasks. J
Int Neuropsychol Soc. 2004;10(4):475-481.
Hindmarch I, Shillingford J, Shillingford C. The effects of sertraline on psychomotor performance in elderly volunteers. J Clin Psychiatry. 1990;51Suppl B:34-36. Hoogenraad TU. Paradigm shift in treatment of Wilson's disease: zinc therapy now
treatment of choice. Brain Dev. 2006;28(3):141-146.
Hooper H. The Hooper Visual Organization Test Manual. Los Angeles: Western Psychological Services, 1958.
Huang CC, Chu NS, Yen TC, Wai YY, Lu CS. Dopamine transporter binding in Wilson's disease. Can J Neurol Sci. 2003;30(2):163-167.
Isaacs-Glaberman K, Medalia A, Scheinberg IH. Verbal recall and recognition abilities in patients with Wilson's disease. Cortex. 1989;25(3):353-361.
Iwamoto K, Takahashi M, Nakamura Y, Kawamura Y, Ishihara R, Uchiyama Y, et al. The effects of acute treatment with paroxetine, amitriptyline, and placebo on driving performance and cognitive function in healthy Japanese subjects: a double-blind crossover trial. Hum Psychopharmacol. 2008;23(5):399-407. Jeon B, Kim JM, Jeong JM, Kim KM, Chang YS, Lee DS, et al. Dopamine
transporter imaging with [123I]-beta-CIT demonstrates presynaptic nigrostriatal dopaminergic damage in Wilson's disease. J Neurol Neurosurg
Psychiatry. 1998;65(1):60-64.
Kaplan EF, Goldglass H, Weintraub S. The Boston Naming Test. 2a. ed. Philadelphia: Lea & Febiger, 1983.
Kerr JS, Powell J, Hindmarch I. The effects of reboxetine and amitriptyline, with and without alcohol on cognitive function and psychomotor performance. Br J Clin
Pharmacol. 1996;42(2):239-241.
King AD, Walshe JM, Kendall BE, Chinn RJ, Paley MN, Wilkinson ID, et al. Cranial MR imaging in Wilson's disease. AJR Am J Roentgenol. 1996;167(6):1579-1584.
Knegtering H, Eijck M, Huijsman A. Effects of antidepressants on cognitive functioning of elderly patients. A review. Drugs Aging. 1994;5(3):192-199. Kozic D, Svetel M, Petrovic B, Dragasevic N, Semnic R, Kostic VS. MR imaging of
the brain in patients with hepatic form of Wilson's disease. Eur J Neurol. 2003;10(5):587-592.
Lai CH, Tseng HF. Population-based epidemiologic study of Wilson's disease in Taiwan. Eur J Neurol. 2010;17(6):830-833.
Lang C, Muller D, Claus D, Druschky KF. Neuropsychological findings in treated Wilson's disease. Acta Neurol Scand. 1990;81(1):75-81.
Larnaout A, Ammar N, Mourad Z, Naji S, Hentati F. Wilson's disease: appreciable improvement of sub-cortical white matter abnormalities after copper chelating treatment: five years follow-up. Neuropediatrics. 2008;39(3):176-178.
Larsson MU, Almkvist O, Luszcz MA, Wahlin TB. Phonemic fluency deficits in asymptomatic gene carriers for Huntington's disease. Neuropsychology. 2008;22(5):596-605.
Lawler GA, Pennock JM, Steiner RE, Jenkins WJ, Sherlock S, Young IR. Nuclear magnetic resonance (NMR) imaging in Wilson disease. J Comput Assist
Tomogr. 1983;7(1):1-8.
Lima CF, Meireles LP, Fonseca R, Castro SL, Garrett C. The Frontal Assessment Battery (FAB) in Parkinson's disease and correlations with formal measures of executive functioning. J Neurol. 2008;255(11):1756-1761.
Littman E, Medalia A, Senior G, Scheinberg IH. Rate of information processing in patients with Wilson's disease. J Neuropsychiatry Clin Neurosci. 1995;7(1):68- 71.
Loudianos G, Gitlin JD. Wilson's disease. Semin Liver Dis. 2000;20(3):353-364. Lucato LT. Avaliação comparativa entre as imagens convencionais de ressonância
magnética e espectroscopia de pósitron na doença de Wilson [tese]. São Paulo:
Faculdade de Medicina, Universidade de São Paulo, 2003.
Lucato LT, Otaduy MC, Barbosa ER, Machado AA, McKinney A, Bacheschi LA, et al. Proton MR spectroscopy in Wilson disease: analysis of 36 cases. AJNR Am
J Neuroradiol. 2005;26(5):1066-1071.
Machado A, Chien HF, Deguti MM, Cancado E, Azevedo RS, Scaff M, et al. Neurological manifestations in Wilson's disease: Report of 119 cases. Mov
Machado AA, Deguti MM, Genschel J, Cancado EL, Bochow B, Schmidt H, et al. (2008). Neurological manifestations and ATP7B mutations in Wilson's disease.
Parkinsonism Relat Disord. 2008;14(3):246-249.
Magalhães AC, Caramelli P, Menezes JR, Lo LS, Bacheschi LA, Barbosa ER, et al. Wilson's disease: MRI with clinical correlation. Neuroradiology. 1994;36(2):97-100.
Matsuura T, Sasaki H, Tashiro K. Atypical MR findings in Wilson's disease: pronounced lesions in the dentate nucleus causing tremor. J Neurol Neurosurg
Psychiatry. 1998; 64(2):161.
Mattis S. Mental status examination for organic mental syndrome in the elderly patients. In: Geriatric phychiatry. New York: Grune & Stratton, 1976.
McCrea M, Cordoba J, Vessey G, Blei AT, Randolph C. Neuropsychological characterization and detection of subclinical hepatic encephalopathy. Arch
Neurol. 1996;53(8):758-763.
McKeith IG, Dickson DW, Lowe J, Emre M, O'Brien JT, Feldman H, et al. Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology. 2005;65(12):1863-1872.
Medalia A. Cognitive impairment in Wilson's disease. J Neuropsychiatry Clin
Neurosci. 1992;4(3):349-350.
Medalia A, Isaacs-Glaberman K, Scheinberg IH. Neuropsychological impairment in Wilson's disease. Arch Neurol. 1988;45(5):502-504.
Medalia A, Scheinberg IH. Intellectual functioning in treated Wilson's disease. Ann
Meenakshi-Sundaram S, Mahadevan A, Taly AB, Arunodaya GR, Swamy HS, Shankar SK. Wilson's disease: a clinico-neuropathological autopsy study. J
Clin Neurosci. 2008;15(4):409-417.
Mochizuki H, Kamakura K, Masaki T, Okano M, Nagata N, Inui A, et al. Atypical MRI features of Wilson's disease: high signal in globus pallidus on T1- weighted images. Neuroradiology, 1997;39(3):171-174.
Molloy SA, Rowan EN, O'Brien JT, McKeith IG, Wesnes K, Burn DJ. Effect of levodopa on cognitive function in Parkinson's disease with and without dementia and dementia with Lewy bodies. J Neurol Neurosurg Psychiatry. 2006;77(12):1323-1328.
Morris JC, Heyman A, Mohs RC, Hughes JP, van BG, Fillenbaum G, et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease. Neurology. 1989;39(9):1159-1165.
Nitrini R, Caramelli P, Herrera JE, Porto CS, Charchat-Fichman H, Carthery MT, et al. Performance of illiterate and literate nondemented elderly subjects in two tests of long-term memory. J Int Neuropsychol Soc. 2004;10(4):634-638. Nitrini R, Lefevre BH, Mathias SC, Caramelli P, Carrilho PE, Sauaia N, et al.
Neuropsychological tests of simple application for diagnosing dementia. Arq
Neuropsiquiatr. 1994;52(4):457-465.
Nóbrega E, Nieto A, Barroso J, Montón F. Differential impairment in semantic, phonemic, and action fluency performance in Friedreich's ataxia: possible evidence of prefrontal dysfunction. J Int Neuropsychol Soc. 2007;13(6):944- 952.
Nyhus E, Barcelo F. The Wisconsin Card Sorting Test and the cognitive assessment of prefrontal executive functions: a critical update. Brain Cogn. 2009;71(3):437-451.
Oder W, Brucke T, Kollegger H, Spatt J, Asenbaum S, Deecke L. Dopamine D2 receptor binding is reduced in Wilson's disease: correlation of neurological deficits with striatal 123I-iodobenzamide binding. J Neural Transm. 1996;103(8-9):1093-1103.
Oder W, Grimm G, Kollegger H, Ferenci P, Schneider B, Deecke L. Neurological and neuropsychiatric spectrum of Wilson's disease: a prospective study of 45 cases. J Neurol. 1991;238(5):281-287.
Oder W, Prayer L, Grimm G, Spatt J, Ferenci P, Kollegger H, et al. Wilson's disease: evidence of subgroups derived from clinical findings and brain lesions.
Neurology, 1993;43(1):120-124.
Oertel WH, Tatsch K, Schwarz J, Kraft E, Trenkwalder C, Scherer J, et al. Decrease of D2 receptors indicated by 123I-iodobenzamide single-photon emission computed tomography relates to neurological deficit in treated Wilson's disease. Ann Neurol. 1992;32(6):743-748.
Petrukhin K, Fischer SG, Pirastu M, Tanzi RE, Chernov I, Devoto M, et al. Mapping, cloning and genetic characterization of the region containing the Wilson disease gene. Nat Genet. 1993;5(4):338-343.
Pfeffer RI, Kurosaki TT, Harrah Jr CH, Chance JM, Filos S. Measurement of functional activities in older adults in the community. J Gerontol. 1982;37(3):323-329.
Piga M, Murru A, Satta L, Serra A, Sias A, Loi G, et al. Brain MRI and SPECT in the diagnosis of early neurological involvement in Wilson's disease. Eur J Nucl
Portala K, Levander S, Westermark K, Ekselius L, von KL. Pattern of neuropsychological deficits in patients with treated Wilson's disease. Eur Arch
Psychiatry Clin Neurosci. 2001;251(6):262-268.
Porto CS, Fichman HC, Caramelli P, Bahia VS, Nitrini R. Brazilian version of the Mattis dementia rating scale: diagnosis of mild dementia in Alzheimer's disease. Arq Neuropsiquiatr. 2003;61(2B):339-345.
Prashanth LK, Taly AB, Sinha S, Ravishankar S, Arunodaya GR, Vasudev MK, et al. Prognostic factors in patients presenting with severe neurological forms of Wilson's disease. QJM. 2005;98(8):557-563.
Prayer L, Wimberger D, Kramer J, Grimm G, Oder W, Imhof H. Cranial MRI in Wilson's disease. Neuroradiology. 1990;32(3):211-214.
Rascovsky K, Salmon DP, Hansen LA, Thal LJ, Galasko D. Disparate letter and semantic category fluency deficits in autopsy-confirmed frontotemporal dementia and Alzheimer's disease. Neuropsychology. 2007;21(1):20-30.
Rathbun JK. Neuropsychological aspects of Wilson's disease. Int J Neurosci. 1996;85(3-4):221-229.
Reilly M, Daly L, Hutchinson M. An epidemiological study of Wilson's disease in the Republic of Ireland. J Neurol Neurosurg Psychiatry. 1993;56(3):298-300. Riley D, Wiznitzer M, Schwartz S, Zinn AB. A 13-year-old boy with cognitive
impairment, retinoblastoma, and Wilson disease. Neurology, 2001;57(1):141- 143.
Roh JK, Lee TG, Wie BA, Lee SB, Park SH, Chang KH. Initial and follow-up brain MRI findings and correlation with the clinical course in Wilson's disease.
Ross BD, Jacobson S, Villamil F, Korula J, Kreis R, Ernst T, et al. Subclinical hepatic encephalopathy: proton MR spectroscopic abnormalities. Radiology, 1994;193(2):457-463.
Rosselli M, Lorenzana P, Rosselli A, Vergara I. Wilson's disease, a reversible dementia: case report. J Clin Exp Neuropsychol. 1987;9(4):399-406.
Rudkin TM, Arnold DL. Proton magnetic resonance spectroscopy for the diagnosis and management of cerebral disorders. Arch Neurol. 1999;56(8):919-926. Saatci I, Topcu M, Baltaoglu FF, Kose G, Yalaz K, Renda Y, et al. Cranial MR
findings in Wilson's disease. Acta Radiol. 1997;38(2):250-258.
Salinsky MC, Spencer DC, Oken BS, Storzbach D. Effects of oxcarbazepine and phenytoin on the EEG and cognition in healthy volunteers. Epilepsy Behav. 2004;5(6):894-902.
Scheinberg IH, Sternlieb I. Wilson's disease. Philadelphia: Saunders, 1984.
Scheinberg IH, Sternlieb I, Walshe JM. Wilson's disease and Kayser-Fleischer rings.
Ann Neurol. 1986;19(6):613-614.
Schlaug G, Hefter H, Engelbrecht V, Kuwert T, Arnold S, Stocklin G, et al. Neurological impairment and recovery in Wilson's disease: evidence from PET and MRI. J Neurol Sci. 1996;136(1-2):129-139.
Schmahmann JD, Sherman JC. The cerebellar cognitive affective syndrome. Brain. 1998;121( Pt 4):561-579.
Seniow J, Bak T, Gajda J, Poniatowska R, Czlonkowska A. Cognitive functioning in neurologically symptomatic and asymptomatic forms of Wilson's disease. Mov
Sinha S, Christopher R, Arunodaya GR, Prashanth LK, Gopinath G, Swamy HS, et al. Is low serum tocopherol in Wilson's disease a significant symptom? J
Neurol Sci. 2005;228(2):121-123.
Sinha S, Jha DK, Sinha KK. Wilson's disease in Eastern India. J Assoc Physicians
India. 2001;49:881-884.
Sinha S, Taly AB, Prashanth LK, Ravishankar S, Arunodaya GR, Vasudev MK. Sequential MRI changes in Wilson's disease with de-coppering therapy: a study of 50 patients. Br J Radiol. 2007;80(957):744-749.
Sinha S, Taly AB, Ravishankar S, Prashanth LK, Vasudev MK. Central pontine signal changes in Wilson's disease: distinct MRI morphology and sequential changes with de-coppering therapy. J Neuroimaging. 2007;17(4):286-291. Sinha S, Taly AB, Ravishankar S, Prashanth LK, Vasudev MK. Wilson's disease:
(31)P and (1)H MR spectroscopy and clinical correlation. Neuroradiology. 2010.
Sinha S, Taly AB, Ravishankar S, Prashanth LK, Venugopal KS, Arunodaya GR, et al. Wilson's disease: cranial MRI observations and clinical correlation.
Neuroradiology. 2006;48(9):613-621.
Snow BJ, Bhatt M, Martin WR, Li D, Calne DB. The nigrostriatal dopaminergic pathway in Wilson's disease studied with positron emission tomography. J
Neurol Neurosurg Psychiatry. 1991;54(1):12-17.
Spreen O, Strauss E. Executive Function. In: A compendium of neuropsychological
Starosta-Rubinstein S, Young AB, Kluin K, Hill G, Aisen AM, Gabrielsen T, et al. Clinical assessment of 31 patients with Wilson's disease. Correlations with structural changes on magnetic resonance imaging. Arch Neurol. 1987;44(4):365-370.
Stracciari A, Tempestini A, Borghi A, Guarino M. Effect of liver transplantation on neurological manifestations in Wilson disease. Arch Neurol. 2000;57(3):384- 386.
Strecker K, Schneider JP, Barthel H, Hermann W, Wegner F, Wagner A, et al. Profound midbrain atrophy in patients with Wilson's disease and neurological symptoms? J Neurol. 2006;253(8):1024-1029.
Stroop J. Studies of interference in serial verbal reactions. J Exp Psychol. 1935;18:643.
Sunderland T, Hill JL, Mellow AM, Lawlor BA, Gundersheimer J, Newhouse PA, et al. Clock drawing in Alzheimer's disease. A novel measure of dementia severity. J Am Geriatr Soc. 1989;37(8):725-729.
Svetel M, Potrebic A, Pekmezovic T, Tomic A, Kresojevic N, Jesic R, et al. Neuropsychiatric aspects of treated Wilson's disease. Parkinsonism Relat
Disord. 2009;15(10):772-775.
Tailarach J, Tournoux P. Co-planar stereotaxic atlas of human brain. New York: Thieme Medical Publishers, Inc, 1988.
Taly AB, Meenakshi-Sundaram S, Sinha S, Swamy HS, Arunodaya GR. Wilson disease: description of 282 patients evaluated over 3 decades. Medicine
Tanzi RE, Petrukhin K, Chernov I, Pellequer JL, Wasco W, Ross B, et al. The Wilson disease gene is a copper transporting ATPase with homology to the Menkes disease gene. Nat Genet. 1993;5(4):344-350.
Tarnacka B, Szeszkowski W, Golebiowski M, Czlonkowska A. MR spectroscopy in monitoring the treatment of Wilson's disease patients. Mov Disord. 2008;23(11):1560-1566.
Teive HAG, Arruda WO. Cognitive dysfunction in Spinocerebellar ataxia. Dementia & Neuropsychologia. 2009;3:180-187.
Van Wassenaer-van Hall HN, Van Den Heuvel AG, Algra A, Hoogenraad TU, Mali WP. Wilson disease: findings at MR imaging and CT of the brain with clinical correlation. Radiology. 1996;198(2):531-536.
Verdelho A, Madureira S, Moleiro C, Ferro JM, Santos CO, Erkinjuntti T, et al. White matter changes and diabetes predict cognitive decline in the elderly: the LADIS study. Neurology. 2010;75(2):160-167.
Verma A, Singh NN, Misra S. Early white matter changes in Wilson disease. J Assoc
Physicians India. 2004;52:578-579.
Walshe JM. History of Wilson's disease: 1912 to 2000. Movement Disorders. 2006;21(2):142-147.
Walshe JM, Yealland M. Wilson's disease: the problem of delayed diagnosis. J
Neurol Neurosurg Psychiatry. 1992;55(8):692-696.